Prostate Specific Antigen Features

CME Articles

PCA3: What Is Its Role in Prostate Cancer Screening?

Although several biomarkers show promise, PCA3 has garnered substantial attention following FDA approval and its role in the diagnosis of PCa will grow.

Latest Prostate Specific Antigen News

PCPs Screening Less with PSA Per USPSTF Recs

PCPs Screening Less with PSA Per USPSTF Recs

Primary care screening patterns have changed as a result of the USPSTF recommendation.

DRE Has Limited Value for Prostate Cancer Screening

DRE Has Limited Value for Prostate Cancer Screening

Biopsies triggered by an abnormal DRE alone were significantly less likely to detect clinically significant prostate cancer than biopsies triggered by an abnormal PSA alone.

Under and Over Imaging in Castration-Resistant Prostate Cancer

Under and Over Imaging in Castration-Resistant Prostate Cancer

Patients with higher PSA, shorter PSA doubling time more likely to have second bone scan.

PSA Rising While on Abiraterone? Taking It with Food May Help

PSA Rising While on Abiraterone? Taking It with Food May Help

In a small study of mCRPC patients, the median time on therapy increased by nearly 100 days and PSA declined in some subjects.

New Guideline for PCa Survivor Care Endorsed by ASCO

New Guideline for PCa Survivor Care Endorsed by ASCO

Guideline outlines recommended follow-up care for prostate cancer survivors

Underdiagnosis Common Among PCa Active Surveillance Candidates

Underdiagnosis Common Among PCa Active Surveillance Candidates

Just over 41% of patients eligible for active surveillance by European standards were found to have undergraded prostate cancer.

PSA Doubling Time Predicts Salvage Radiation Outcomes

PSA Doubling Time Predicts Salvage Radiation Outcomes

PSA doubling time of 6 months or less and seminal vesicle invasion were significant predictors of biochemical recurrence.

Urology Referrals for Elevated PSA Unchanged

Urology Referrals for Elevated PSA Unchanged

New study examined the effect of a U.S. Preventive Services Task Force 2012 recommendation against routine PSA screening.

Optimal PSA Threshold For Targeted Biopsy Identified

Optimal PSA Threshold For Targeted Biopsy Identified

Diagnostic usefulness of magnetic resonance imaging/ultrasound (MRI/US) fusion targeted prostate biopsy optimized in PSA level of 5.2 ng/mL or higher.

Rising PSA with Testosterone Gel Linked with Specific Factors

Rising PSA with Testosterone Gel Linked with Specific Factors

Greater PSA increases seen in older men and those with lower baseline testosterone.

Early Prostate Cancer Post-Operation PSA Values Useful

Early Prostate Cancer Post-Operation PSA Values Useful

PSA levels at day 30 found to predict biochemical relapse risk in men with positive surgical margins.

Good Prostate Cancer (PCa) Outcomes Possible Despite Salvage Radiation Failure

Good Prostate Cancer (PCa) Outcomes Possible Despite Salvage Radiation Failure

Men who had PSA relapse after receiving post-radical surgery salvage radiation therapy had a median overall survival of nearly 14 years.

Palpable Tumors Plus Low PSA May Up Prostate Cancer Death Risk

Palpable Tumors Plus Low PSA May Up Prostate Cancer Death Risk

New study highlights the importance of digital rectal examinations in PCa patients with normal-range PSA at diagnosis.

Lower PSA Predicts Favorable Salvage Radiotherapy Outcomes

Lower PSA Predicts Favorable Salvage Radiotherapy Outcomes

Reduced likelihood of biochemical recurrence of prostate cancer also linked to concomitant hormonal therapy and positive surgical margins.

New Findings May Explain PSA Bounce

New Findings May Explain PSA Bounce

Transient rises in PSA after radiotherapy may be due to late damage to healthy prostatic tissue, evidence suggests.